2,4-双(苯胺基)-6-吗啉-1,3,5-三嗪 | 43167-79-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2,4-双(苯胺基)-6-吗啉-1,3,5-三嗪
• 中文别名: 2,3-二甲基-4-亚硝基苯酚；2,4-二苯胺基-6-(4-吗啉基)-1,3,5-三嗪
• 英文名称: 6-morpholin-4-yl-N,N'-diphenyl-[1,3,5]triazine-2,4-diamine
• 英文别名: 2,4-Dianilino-6-N-morpholino-s-triazine；2,4-Dianilino-6-(4-morpholinyl)-1,3,5-triazine；6-morpholin-4-yl-2-N,4-N-diphenyl-1,3,5-triazine-2,4-diamine
• CAS: 43167-79-9
• 化学式: C₁₉H₂₀N₆O
• 分子量: 348.407
• InChiKey: GSXOUQFSYTZEJF-UHFFFAOYSA-N

物化性质

• 熔点：
  194-196°C

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  75.2
• 氢给体数：
  2
• 氢受体数：
  7

安全信息

• 海关编码：
  2934999090

反应信息

• 作为产物：
  描述：

  吗啉 、 6-氯-N,N'-二苯基-[1,3,5]三嗪-2,4-二胺 以 丙酮 为溶剂， 反应 3.0h， 以96%的产率得到2,4-双(苯胺基)-6-吗啉-1,3,5-三嗪
  参考文献：
  名称：

  Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives

  摘要：

  A series of triaminotriazine derivatives (compounds 5a-f, 6a-x, and 7a-g) was designed, synthesized, and evaluated for their inhibition activities to colorectal cancer (CRC) cell lines (HCT-116 and HT-29). Most of the synthesized compounds demonstrated moderate anti-proliferatory effects on both HCT-116 and HT-29 cell lines at the concentration of 10 mu M. The inhibitory activities against HCT-116 and HT-29 cell lines were discussed to develop the structure-activity relationships of this new series. Compounds 61 and 6o exhibited prominent inhibition activities toward HCT-116, with IC50S of 0.76 and 0.92 mu M, respectively. The in vivo antitumor studies and pharmacokinctics of compound 61 showed that it might be a promising new hit for further development of antitumor agents. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.11.028

文献信息

• Caubere,P.; Parry,D., Bulletin de la Societe Chimique de France, 1973, p. 2112 - 2115
  作者：Caubere,P.、Parry,D.

  DOI：——

  日期：——
• COMPOUNDS AND METHODS FOR TREATING DISEASES CAUSED BY SARS-COV-2 AND OTHER CORONAVIRUSES
  申请人：[en]VIRADEM INC.

  公开号：WO2024151953A1

  公开（公告）日：2024-07-18

  Provided are compounds and methods of treating diseases caused by a Coronaviridae virus such as SARS-CoV-2, SARS-CoV, and MERS-CoV coronaviruses by administering nitrogen-containing heterocyclic compounds. SARS (Severe Acute Respiratory Syndrome), MERS (Middle East Respiratory Syndrome), and, particularly, COVID-19 are highly contagious diseases with high mortality rate responsible for tens of millions of infections and almost two million deaths around the globe.
• Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives
  作者：Mingfang Zheng、Chenghui Xu、Jianwei Ma、Yan Sun、Feifei Du、Hong Liu、Liping Lin、Chuan Li、Jian Ding、Kaixian Chen、Hualiang Jiang

  DOI：10.1016/j.bmc.2006.11.028

  日期：2007.2

  A series of triaminotriazine derivatives (compounds 5a-f, 6a-x, and 7a-g) was designed, synthesized, and evaluated for their inhibition activities to colorectal cancer (CRC) cell lines (HCT-116 and HT-29). Most of the synthesized compounds demonstrated moderate anti-proliferatory effects on both HCT-116 and HT-29 cell lines at the concentration of 10 mu M. The inhibitory activities against HCT-116 and HT-29 cell lines were discussed to develop the structure-activity relationships of this new series. Compounds 61 and 6o exhibited prominent inhibition activities toward HCT-116, with IC50S of 0.76 and 0.92 mu M, respectively. The in vivo antitumor studies and pharmacokinctics of compound 61 showed that it might be a promising new hit for further development of antitumor agents. (c) 2006 Elsevier Ltd. All rights reserved.